FILTER
LATEST INTERVIEWS
Fernando de la Lastra & Joerg von Loebenstein
GENERAL MANAGER AND CO-FOUNDER & ENGINEERING MANAGER AND CO-FOUNDER, TECNIPAK
Technopak in Chile explains how its specialisation in mineral conveyer systems offers global potential.
Riccardo Palmisano
PRESIDENT, ASSOBIOTEC
Federchimica Assobiotec explains how the association is striving to help Italy’s biotech industry reach the scale that its’ potential offers.
Martin Preece
EXECUTIVE VICE PRESIDENT SOUTH AFRICA, GOLD FIELDS
Gold Fields relates how its’ South Deep mine in South Africa is perfoming.
Joseph Lee Ching Hua
HEAD OF CO-INNOVATION CENTRE & GENERAL MANAGER OF DEVELOPMENT CENTRE, YOKOGAWA SOUTHEAST ASIA
Yokogawa SE Asia helps companies in the areas of measurement, control and information for the industrial automation industry.
Ganapathy Swamy
MANAGING DIRECTOR, SINGAPORE & THE HEAD OF ONSITE ACCOUNTS, LINDE ASEAN
Linde in Singapore describes to GBR its expansion plans for SE Asia.
Benjamin Quijandria
CEO, MINING CLUSTER OF SOUTHERN PERU (CMSP)
Mining Cluster if Southern Peru (CMSP) explains how it was inspired into being by the success of the mining clusters in Chile and Australia.
Réjean Girard
PRESIDENT, IOS SERVICES GÉOSCIENTIFIQUES
IOS explains to GBR why its solutions to technical, scientific and operational problems for mines are now more important than ever.
Josée Méthot
PRESIDENT & CEO, QUÉBEC MINING ASSOCIATION (QMA)
The Québec Mineral Association discusses the outlook for the region’s mining industry.
Darrell White
EXECUTIVE GENERAL MANAGER AMERICAS, THIESS
Thiess is upbeat on adding more services and expanding its operations in Chile.
Marco Riveros
VICE PRESIDENT, CHILEAN COPPER COMMISSION (COCHILCO)
The Chilean Copper Commission (Cochilco) speaks to GBR about how it assisted Chile’s copper industry through a difficult period.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
